These projects were made possible from Cure Alzheimer's Fund support.
| Project Description | Researchers | Funding |
|---|---|---|
| Microbiome Consortium: Interaction of the Microbiome with Astrocytes and Amyloid Pathology |
2023 $345,000 |
|
| Alzheimer’s Disease Tau Consortium: The Role of Amyloid Beta-Induced Membrane Damage in Tau Pathology |
2022 $286,356.90 |
|
| Single Nucleus RNA Sequencing Analysis of ACE1 R1284Q Knock-in Mice |
2022 $246,804 |
|
| Single Nucleus RNA Sequencing Analysis of ACE1 R1284Q Knockin Mice |
2020 $234,796 |
|
| Molecular and Cellular Mechanisms of ACE1 Variant in Alzheimer’s Disease |
2015, 2017, 2019 $1,000,000 |
|
| Investigations of the Mechanism of Action of TagretinR/Bexarotene on Amyloid Clearance in Transgenic Mouse Models |
2012 $50,343 |
|
| The roles of Eps homology domain (EHD) proteins and synaptic activity in axon transport of the Alzheimer’s Beta-secretase BACE1 in the brain |
2012, 2013 $200,000 |
These published papers resulted from Cure Alzheimer’s Fund support.
Riqiang Yan, Robert Vassar Targeting the β secretase BACE1 for Alzheimer’s disease therapy, The Lancet Neurology, 13(3), March 2014, 319 - 329, Read More
